{
  "docId": "019de515-bf16-778d-9d2b-a6c6e17ebc6c",
  "docSlug": "7a45cce2c7eb1605e2a52f1d1ebe6b6d",
  "documentTitle": "MaxCyte | Investor Presentation Deck | 20 slides",
  "authorId": "maxcyte",
  "authorName": "MaxCyte",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 17,
  "pageCount": 20,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 13,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/17",
  "deckHref": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c",
  "deckJsonHref": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json",
  "deckAnchorHref": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-17",
  "components": [
    {
      "bbox": {
        "h": 0.53,
        "w": 0.48,
        "x": 0.04,
        "y": 0.13
      },
      "kind": "chart",
      "text": "Revenues ($M) FY 2021: Cell Therapy $23.0M, Drug Discovery $8.4M, Program-related $2.5M, Total $33.9M. FY 2022: Cell Therapy $30.5M (+33%), Drug Discovery $9.1M (+8%), Program-related $4.6M (+83%), Total $44.3M (+31%).",
      "attrs": {
        "series": [
          "Cell Therapy",
          "Drug Discovery",
          "Program-related"
        ],
        "x_axis_label": "Fiscal Year",
        "y_axis_label": "Revenues ($M)"
      },
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "29038a5c-696b-4c47-be6c-9c2cc94728c4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.47,
        "w": 0.31,
        "x": 0.59,
        "y": 0.13
      },
      "kind": "chart",
      "text": "Operating Expenses ($M) FY 2021: $48.4M. FY 2022: $66.5M.",
      "attrs": {
        "x_axis_label": "Fiscal Year",
        "y_axis_label": "Operating Expenses ($M)"
      },
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c621b0c-4ac5-4b1d-8f3c-762649dad594",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.13,
        "x": 0.8,
        "y": 0.06
      },
      "kind": "image",
      "text": "MaxCyte logo",
      "attrs": {},
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0a5d74b9-45b1-4086-8694-2f0b84246d16",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.14,
        "x": 0.21,
        "y": 0.78
      },
      "kind": "metric",
      "text": "Gross Margins ~88%",
      "attrs": {},
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4373b41d-9171-468a-bdc2-21c9896a9aa7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.36,
        "x": 0.57,
        "y": 0.78
      },
      "kind": "paragraph",
      "text": "Balance Sheet\nTotal cash, cash equivalents and short-term investments were $227.3 million as of December 31, 2022.",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "52c63ec2-9b7a-40c7-8cd5-92de612404e7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.32,
        "x": 0.59,
        "y": 0.63
      },
      "kind": "paragraph",
      "text": "The overall increase in operating expenses was principally driven by increases in headcount, occupancy and public company expenses.",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "96f499fb-4aae-47ec-97cd-fde3172a3675",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.01,
        "w": 0.16,
        "x": 0.82,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "© 2023 MaxCyte, Inc. All Rights Reserved",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6dbb684e-02d6-42c8-b8b7-12d95af8f833",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.37,
        "x": 0.08,
        "y": 0.71
      },
      "kind": "subtitle",
      "text": "31% Year-Over-Year Total Revenue Growth in 2022",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a99a7a1c-5bae-4fc9-aa62-5fbdfda13903",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.44,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "FY 2022 Key Financial Highlights",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "71b8abae-d4ef-46c4-81fd-ae657cf6e1c2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 18,
      "from": 16,
      "beatId": "ed3501a8-1588-4478-bdb3-f37f6797fdb4",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Financials",
      "beatSlug": "sequoia-pitch-financials",
      "evidence": "The deck presents financial information from page 16 to 18.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}